• Publications
  • Influence
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR, and these data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence.
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
At 1 year, ILI resulted in clinically significant weight loss in people with type 2 diabetes and was associated with improved diabetes control and CVD risk factors and reduced medicine use in ILI versus DSE.
Global prevalence and major risk factors of diabetic retinopathy.
The Meta-Analysis for Eye Disease (META-EYE) Study Group’s Global Prevalence and Major Risk Factors of Diabetic Retinopathy and Diabetes care, 35 (3).
The Homeostasis Model in the San Antonio Heart Study
HOMA provides a useful model to assess insulin resistance and β-cell function in epidemiological studies in which only fasting samples are available and that, further, it is critical to take into account the degree of insulin resistance in assessing insulin secretion by the HOMA model.
The prevalence of diabetic retinopathy among adults in the United States.
OBJECTIVE To determine the prevalence of diabetic retinopathy among adults 40 years and older in the United States. METHODS Pooled analysis of data from 8 population-based eye surveys was used to
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
Lowering the fasting glucose cutoff to 5.4 mmol/l improves the prediction of diabetes by the metabolic syndrome, and the NCEP definition performs better than the modified 1999 WHO definition.
The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial
The prevalence of the metabolic syndrome at baseline in the trial population is addressed and how this varies by age and sex and whether the 2 interventions reduced the incidence of new cases of the metabolism syndrome or increased resolution of existing cases compared with placebo is addressed.
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
It is suggested that diabetic patients without previous myocardial infarction have as high a risk of myocardia infarctions as nondiabetic patients with previous my Cardiac Arrest.
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
The metabolic syndrome is inferior to established predicting models for either type 2 diabetes or CVD and combined with either predicting model did not improve the prediction of either end point.
Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test?
A need has arisen to identify persons at high risk for diabetes so that physicians can offer them preventive interventions and develop multivariable models that use readily available clinical variables to predict the development of diabetes.